Jane Ramsdale

553 total citations
8 papers, 436 citations indexed

About

Jane Ramsdale is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Jane Ramsdale has authored 8 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Jane Ramsdale's work include Cancer-related Molecular Pathways (3 papers), Cell death mechanisms and regulation (2 papers) and Cervical Cancer and HPV Research (2 papers). Jane Ramsdale is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Cell death mechanisms and regulation (2 papers) and Cervical Cancer and HPV Research (2 papers). Jane Ramsdale collaborates with scholars based in United Kingdom. Jane Ramsdale's co-authors include P J Guillou, Abeezar Sarela, Michael Wells, Claire L. Davies, Alex Markham, Caroline S. Verbeke, Richard Hutson, Nigel Scott, Alexander F. Markham and Devinder Arora and has published in prestigious journals such as British Journal of Cancer, The Journal of Pathology and Annals of Surgical Oncology.

In The Last Decade

Jane Ramsdale

7 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Ramsdale United Kingdom 6 237 183 87 73 62 8 436
Annie-France Bringuier France 12 170 0.7× 89 0.5× 63 0.7× 71 1.0× 42 0.7× 15 390
John D. Nash United States 12 177 0.7× 162 0.9× 254 2.9× 79 1.1× 84 1.4× 20 595
Kuo‐Chang Wen Taiwan 12 216 0.9× 102 0.6× 81 0.9× 78 1.1× 99 1.6× 28 435
C. Von Kap-Herr United States 11 197 0.8× 105 0.6× 60 0.7× 42 0.6× 45 0.7× 18 545
Hedda H. van Ravenswaay Claasen Netherlands 7 127 0.5× 154 0.8× 61 0.7× 30 0.4× 43 0.7× 10 401
Chietaka Ohmi Japan 12 203 0.9× 102 0.6× 81 0.9× 220 3.0× 52 0.8× 26 462
Christopher Taylor United States 3 156 0.7× 179 1.0× 131 1.5× 29 0.4× 58 0.9× 6 494
Hung-Cheng Lai Taiwan 9 248 1.0× 101 0.6× 66 0.8× 67 0.9× 118 1.9× 29 461
Susanne Sprung Austria 12 195 0.8× 221 1.2× 45 0.5× 72 1.0× 132 2.1× 30 456
D-A Silasi United States 6 147 0.6× 168 0.9× 89 1.0× 30 0.4× 87 1.4× 12 428

Countries citing papers authored by Jane Ramsdale

Since Specialization
Citations

This map shows the geographic impact of Jane Ramsdale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Ramsdale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Ramsdale more than expected).

Fields of papers citing papers by Jane Ramsdale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Ramsdale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Ramsdale. The network helps show where Jane Ramsdale may publish in the future.

Co-authorship network of co-authors of Jane Ramsdale

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Ramsdale. A scholar is included among the top collaborators of Jane Ramsdale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Ramsdale. Jane Ramsdale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sarela, Abeezar, Caroline S. Verbeke, Jane Ramsdale, et al.. (2002). Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma. British Journal of Cancer. 86(6). 886–892. 152 indexed citations
2.
Sarela, Abeezar, Nigel Scott, Jane Ramsdale, Alexander F. Markham, & P J Guillou. (2001). Immunohistochemical Detection of the Anti-Apoptosis Protein, Survivin, Predicts Survival After Curative Resection of Stage II Colorectal Carcinomas. Annals of Surgical Oncology. 8(4). 305–310. 105 indexed citations
3.
Sarela, Abeezar, et al.. (2000). P53 POSITIVE COLORECTAL CARCINOMAS OVEREXPRESS BCL-2. 87(1). 72–72.
4.
Arora, Devinder, et al.. (1999). p53 but not bcl‐2 is expressed by most cholangiocarcinomas: a study of 28 cases. Histopathology. 34(6). 497–501. 27 indexed citations
5.
Maitland, Norman J., Nafisa Wilkinson, Jane Ramsdale, et al.. (1998). Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high-grade cervical intraepithelial neoplasia. The Journal of Pathology. 186(3). 275–280. 32 indexed citations
6.
Maitland, Norman J., Nafisa Wilkinson, Jane Ramsdale, et al.. (1998). Expression patterns of the human papillomavirus type 16 transcription factor E2 in lowâ and highâgrade cervical intraepithelial neoplasia. The Journal of Pathology. 186(3). 275–280. 1 indexed citations
7.
Arora, Devinder, et al.. (1997). IMMUNOHISTOCHEMICAL EXPRESSION OF INHIBIN/ACTIVIN SUBUNITS IN EPITHELIAL AND GRANULOSA CELL TUMOURS OF THE OVARY. The Journal of Pathology. 181(4). 413–418. 50 indexed citations
8.
Hutson, Richard, Jane Ramsdale, & Michael Wells. (1995). p53 protein expression in putative precursor lesions of epithelial ovarian cancer. Histopathology. 27(4). 367–371. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026